ArticleInternational journal of cancer2019

Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers.

Susmita Mondal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.